Immune reconstitution after bone marrow transplantation for combined immunodeficiencies: Down-modulation of Bcl-2 and high expression of CD95/Fas account for increased susceptibility to spontaneous and activation-induced lymphocyte cell death

Bone Marrow Transplantation

Volumn 23, Issue 5, 1999, Pages 451-457

  Brugnoni, D ^b   Airo P ^a   Pennacchio, M ^b   Carella, G ^b   Malagoli, A ^b   Ugazio, A G ^b   Porta, F ^b   Cattaneo, R ^b  

^a SPEDALI CIVILI   (Italy)

^b NONE

Author keywords

Apoptosis; Bcl 2; Bone marrow transplant; Fas; Severe combined immunodeficiency

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; FAS ANTIGEN; PROTEIN BCL 2;

ADOLESCENT; ADULT; APOPTOSIS; ARTICLE; BONE MARROW TRANSPLANTATION; CELL DEATH; CHILD; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; LYMPHOCYTE; MALE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; T LYMPHOCYTE SUBPOPULATION;

EID: 0032976288     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1701608     Document Type: Article

References (34)

1. Fischer A, Landais P, Freidrich W et al. European experience of bone marrow transplantation for SCID. Lancet 1990; 336: 850-854.
2. Fischer A, Landais P, Freidrich W et al. Bone marrow transplantation (BMT) in Europe for primary immunodeficiencies other than severe combined immunodeficiencies: a report from the European Group for BMT and the European Group for immunodeficiencies. Blood 1994; 83: 1149-1155.
3. Donnenberg AD, Margolick JB, Beltz LA et al. Apoptosis parallels lymphopoiesis in bone marrow transplantation and HIV disease. Res Immunol 1995; 146: 11-21.
4. Yang E, Korsmeyer SJ. Molecular thanatopsis: a discourse on the BCL2 family and cell death. Blood 1996; 88: 386-401.
5. Strasser A, Harris AW, Huang DCS et al. Bcl-2 and Fas/APO-1 regulate distinct pathways to lymphocyte apoptosis. EMBO J 1996; 14: 6136-6147.
6. Van Parijs L, Ibramighov A, Abbas AK. The roles of costimulation and Fas in T cell apoptosis and peripheral tolerance. Immunity 1996; 4: 321-328.
7. Van Parijs L, Abbas AK. Role of Fas-mediated cell death in the regulation of immune responses. Curr Opin Immunol 1996; 8: 355-361.
8. Miyawaki T, Uehara T, Nibu R et al. Differential expression of apoptosis-related Fas antigen on lymphocyte subpopulations in human peripheral blood. J Immunol 1992; 149: 3753-3758.
9. Dhein J, Daniel PT, Trauth BC et al. Induction of apoptosis by monoclonal antibody anti-APO-1 class switch variants is dependent on cross-linking of APO-1 cell surface antigens. J Immunol 1992; 149: 3166-3173.
10. Suda T, Nagata S. Purification and characterization of the Fas-ligand that induces apoptosis. J Exp Med 1994; 179: 873-879.
11. Owen-Schaub LB, Yonehara S, Crump III WL, Grimm EA. DNA fragmentation and cell death are selectively triggered in activated human lymphocytes by Fas antigen engagement. Cell Immunol 1992; 140: 197-205.
12. Wesselborg S, Janssen O, Kabelitz D. Induction of activation-driven death (apoptosis) in activated but not resting peripheral blood T cells. J Immunol 1993; 150: 4338-4345.
13. Atkinson K. T cell subpopulations defined by monoclonal antibodies after human bone marrow transplantation. II. Activation and functional subsets of the helper-inducer and cytotoxic-suppressor subpopulations defined by two colour fluorescence flow cytometry. Bone Marrow Transplant 1986; 1: 121-132.
14. Leino L, Lilius EM, Nikoskeleainen J et al. The reappearance of 10 differentiation antigens on peripheral blood lymphocytes after allogeneic bone marrow transplantation. Bone Marrow Transplant 1991; 8: 339-344.
15. + lymphocyte subsets after allogeneic BMT (letter). Bone Marrow Transplant 1993; 11: 346.
16. Storek J, Witherspoon RP, Storb R. T cell reconstitution after bone marrow transplantation into adult patients does not resemble T cell development in early life. Bone Marrow Transplant 1995; 16: 413-425.
17. +) T-helper cells after human allogeneic bone marrow transplantation. Blood 1997; 90: 850-857.
18. Cooley MA, McLachan K, Atkinson K. Cytokine activity after human bone marrow transplantation. III. Defect in IL-2 production by peripheral blood mononuclear cells is not corrected by stimulation with Ca++ ionophor plus phorbol ester. Br J Haematol 1989; 73: 341-347.
19. Dickinson AM, Reid MM, Abinum M et al. In vitro T cell depletion using Campath 1M for mismatched BMT for severe combined immunodeficiency (SCID). Bone Marrow Transplant 1997; 19: 323-329.
20. + T cells after bone marrow transplantation from unrelated donors for combined immunodeficiency. Blood 1998; 92: 3484-3485.
21. Airò P, Brugnoni D, Malagoli A et al. Relevance of donor source on the T cell regeneration after bone marrow transplantation for severe combined immunodeficiency. Haematologica 1999 (in press).
22. Nicoletti I, Migliorati G, Pagliacci MC et al. A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J Immunol Meth 1991; 139: 271-279.
23. Bettinardi A, Brugnoni D, Quiròs-Roldan E et al. Missense mutations in the Fas gene resulting in autoimmune lymphoproliferative syndrome: a molecular and immunological analysis. Blood 1997; 89: 902-909.
24. Vogt RF, Cross GD, Henderson LO, Phillips DL. Model system evaluating fluorescein-labeled microbeads as internal standards to calibrate fluorescence intensity of flow cytometers. Cytometry 1989; 10: 294-301.
25. Haddad E, Landais P, Friedreich W et al. Long-term immune reconstitution and outcome after HLA-nonidentical T cell-depleted bone marrow transplantation for severe combined immunodeficiency: a European retrospective study of 116 patients. Blood 1998; 91: 3646-3653.
26. Atkinson K, Hansen JA, Storb R et al. T cell subpopulations identified by monoclonal antibodies after human bone marrow transplantation. I. Helper-inducer and cytotoxic-suppressor subsets. Blood 1982; 59: 1292-1297.
27. Kook H, Goldman F, Padley D et al. Reconstitution of the immune system after unrelated or partially matched T cell-depleted bone marrow transplantation in children: immunophenotyping analysis and factors affecting the speed of recovery. Blood 1996; 88: 1089-1097.
28. Pignata C, Sanghera JS, Soiffier RJ et al. Defective activation of mitogen-activated protein kinase after allogeneic bone marrow transplantation. Blood 1996; 88: 2334-2341.
29. + T cell memory, CD45R subsets and the persistence of antigen - a unifying concept. Immunol Today 1998; 19: 60-64.
30. Mackall CL, Granger L, Sheard MA et al. T cell regeneration after bone marrow transplantation: differential CD45 isoform expression on thymic-derived vs thymic-independent progeny. Blood 1993; 82: 2585-2594.
31. Mackall CL, Hakim FT, Gress RE. T cell regeneration: all repertoires are not created equal. Immunol Today 1997; 18: 245-251.
32. Salmon M, Pilling D, Borthwick NJ et al. The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur J Immunol 1994; 24: 892-899.
33. Roux E, Helg C, Dumont-Girard F et al. Analysis of T cell repopulation after allogeneic bone marrow transplantation: significant differences between recipients of T cell-depleted and unmanipulated grafts. Blood 1996; 87: 3984-3992.
34. Porta F, Mazzolari E, Lanfranchi A et al. Immunological reconstitution after bone marrow transplantation. Bone Marrow Transplant 1996; 18 (Suppl. 2): 148-150.